Sign in
4

Changes in Ownership

Avalo Therapeutics, Inc. Filed Acc 0001192482-20-000595

Options or other derivatives

  • Director acquired 3,812 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Gutry Phil · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2020-06-30 Grant or award : show line 1 in the form Stock Option (Right to Buy) +3,812 $2.60 2030-06-30 3,812 3,812 D
Loading xslF345X03/edgar.xml…